Trial Profile
A study of ST-403 for Brain metastases and Glioblastoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs ST 403 (Primary)
- Indications Brain metastases; Glioblastoma
- Focus Adverse reactions
- Sponsors Pascal Biosciences
- 08 Nov 2018 New trial record
- 05 Nov 2018 According to Pascal Biosciences media release, study is expected to start in 2019